
Last updated: May 29, 2026 · Medically reviewed by: Dr. Hamza Gemici
Localized article
This article is available in English. Some phrasing may continue to receive editorial refinement.
Quick Summary · TL;DR
Female jawline aesthetics, unlike the masculine "wide and angular" contour, aims for a "soft egg line." Masseter botox creates a slim-down by reducing muscle volume; micro chin and cheek filler provides projection and apex definition; HIFU tightens the SMAS layer, preserving lower face definition. In Dr. Hamza Gemici's clinical protocol, these three technologies are not applied in the same session but layered at 4-6 week intervals; the risk of over-masculinization, pillow face, and sausage jaw is minimized with anatomy-based planning.
Key Takeaways
Summary (TL;DR): Female jawline and face contour aesthetics, unlike the "angular and wide" masculine lower face, aims for a "soft egg line" — a feminine inverted triangle. This goal is not achieved with a single treatment. In my clinical practice, three separate technologies are applied in layers: masseter botox reduces muscle volume, creating a "slim-down" in the lower face; micro chin and cheek filler provides projection and apex definition; HIFU tightens the SMAS layer, preserving mandibular line clarity. This triple protocol is not applied in the same session but at 4-6 week intervals according to anatomical priority. Incorrect sequencing leads to difficult-to-reverse results such as over-masculinization (masculine angular appearance), pillow face (volume overload), and sausage jaw (cylindrical chin). Results vary depending on the individual, age, bone anatomy, and lifestyle. Dr. Hamza Gemici — Ondokuz Mayıs University Faculty of Medicine graduate, 30+ years of medical aesthetic experience, ORCID 0009-0007-8058-2774.
In female facial aesthetics, the "jawline" — that is, the chin line — has become the most requested anatomical area in the last decade. While the exaggerated "sharp jawline" aesthetic of social media filters raises expectations, patients who come to the clinic saying "I want that sharp jawline too" are often unknowingly pointing to a masculine contour. However, in female facial anatomy, aesthetic balance arises not from the sharpness of the jawline, but from the soft proportion between the upper face (zygomatic) width and the lower face (mandibular) narrowness. This proportion is referred to in the literature as the feminine inverted triangle or heart-shaped face geometry.
I am a graduate of Ondokuz Mayıs University Faculty of Medicine. Throughout my 30+ years of medical aesthetic experience, I have observed how much lower face contour treatments have developed in number and technique, especially in the last decade. "Jawline contouring," which was attempted with filler alone in the 2015s, has today evolved into a protocol where a trio of masseter botox, hyaluronic acid filler, and energy-based skin tightening (HIFU or RFM) are planned in layers. The guide below is a summary of both scientific literature and this clinical observation. ORCID 0009-0007-8058-2774.
Dr. Gemici's note: The first thing I tell most of my female patients who come for a consultation saying "I want a sharp jawline" is: "Let's look in the mirror together first." Because many patients — especially in the 25-35 age range — want to apply a masculine contour reference to their feminine faces. The correct goal is not "sharp"; it is a lower face that is "defined but soft," "slim but balanced." Understanding this difference is half the treatment.
The first step in planning female face contour treatment is the correct classification of the existing face type. In aesthetic anthropometry literature, the female face is divided into five main morphologies: oval, heart, triangle (inverted), square, and oblong. Lewis et al.'s 2014 study on female facial proportions published in JAMA Facial Plastic Surgery (Lewis et al., 2014) showed that these morphologies can be defined with objective criteria (bizygomatic width, bigonial width, facial height).
The oval face is the reference morphology considered "ideal" in classical aesthetic literature — but in the clinic, the definition of "ideal" varies from person to person, so the goal of treatment is not to transform into an oval face, but to balance the proportion in the existing morphology. In an oval face, facial length is approximately 1.5 × bizygomatic width, the chin apex is slightly pointed in the midline, and the gonial angle is soft. In this morphology, lower face contour treatment is planned at a minimal intervention (refinement) level.
A heart-shaped face is a combination of a wide upper forehead + narrow chin + prominent zygoma. It is a classic feminine morphology; the need for treatment in the lower face is usually low; however, as age progresses, mid-face volume loss can lead to the chin apex appearing "too pointed" — in this case, micro chin filler (1-1.5 ml) softens the projection.
The inverted triangle morphology — a more prominent version of the heart-shaped face — has a prominent upper face width and a narrow, pointed lower face. If there is masseter muscle hypertrophy in this face type, botox to slim the muscle can make the lower face appear more pointed; in this case, masseter botox dose and injection point selection should be done carefully.
In a square face, the bigonial width is close to the bizygomatic width; the gonial angle is prominent and sharp. This morphology is close to the male face type and is the most common indication in feminization-targeted treatments. Park et al.'s 2018 study on the Asian jawline published in Plastic and Reconstructive Surgery (Park et al., 2018) showed that masseter botox could reduce bigonial width by an average of 4.3 mm in Asian women with square faces.
In an oblong face, facial height is high relative to bizygomatic width. The goal of lower face contour treatment in this morphology is balanced: avoiding excessive projection in the chin apex and supporting mid-face volume are essential.
One of the most critical moments of a clinical consultation is agreeing with the patient on the definition of a "feminine jawline." Because a significant portion of the references circulating on social media with the "snatched jawline" tag anatomically produce a masculinized (masculine) appearance. In the surgical feminization literature (Capitán et al., 2014, Plastic and Reconstructive Surgery), gender-specific lower face differences are clearly defined:
| Anatomical Region | Masculine (Male) | Feminine (Female) |
|---|---|---|
| Gonial angle | Sharp (approx. 120°) | Soft (approx. 130°) |
| Bigonial width | Wide, close to bizygomatic width | Narrow, 75-80% of bizygomatic width |
| Chin apex (menton) | Wide, square, slightly projected forward | Narrow, slightly pointed, moderate projection |
| Masseter muscle volume | Prominent, testosterone-dependent | Slim, hypertrophic if bruxism is present |
| Mandible body height | High | Lower |
This table is the anatomical answer to the question, "why do some social media jawline references look wrong on a feminine face?" The combination of sharp gonial angle + wide bigonial distance in male models, when applied to a female face, gives the face an "aggressive," "masculine," or "aged" look. The goal of a feminine jawline is the exact opposite: a soft gonial angle, a narrow bigonial distance, and a gently defined chin apex.
Dr. Gemici's note: A common mistake I encounter in my clinical practice, especially in women aged 25-35, is their desire to have filler injected into the masseter area due to the influence of the "sharp jawline" filter. However, applying filler to this area — especially the gonial point region — creates precisely masculine masculinization in a female face. The correct approach is the opposite: it is necessary to reduce the muscle volume in this area (masseter botox), not add filler.
Masseter botox is the cornerstone of female jawline treatment. The masseter is a powerful chewing muscle extending from the mandibular body to the posterior zygoma; when hypertrophied due to overuse (bruxism, tight teeth clenching), genetics, or a hard food diet, it creates bilateral fullness in the lower face and a "square face" appearance. Botulinum toxin type A temporarily reduces the contraction ability of this muscle by blocking acetylcholine release at the neuromuscular junction; as a result, the unused muscle atrophies and its volume decreases.
Lewis et al.'s 2014 study showed that functional weakening of the muscle begins within 2-3 weeks after masseter botox, measurable volume reduction can be documented by MRI from the 4th week, and maximum efficacy is seen between 8-12 weeks. The duration of effect varies between 4-6 months depending on the botulinum toxin type, dose, and the patient's metabolic activity.
In my clinical practice, the masseter botox dose is determined individually in the range of 20-30 units/side, depending on the degree of muscle hypertrophy. Three classic injection points are used: inferior gonion, middle masseter, and anterior mid-masseter. The danger zone (Yamauchi danger zone) — the upper-anterior masseter region where the marginal mandibular branch of the facial nerve passes — is an area to be avoided, especially in women with thin faces; high-dose injection in this area can create temporary asymmetric smiling.
Masseter botox provides a dual benefit, especially in female patients with bruxism (night teeth grinding, jaw clenching): on the one hand, it slims the lower face by reducing muscle hypertrophy, and on the other hand, it alleviates pain and headache complaints by reducing temporomandibular joint (TMJ) pressure. In my clinical practice, masseter botox is the first-line treatment for patients with both bruxism and contour desire.
Caution is required when applying masseter botox in thin-faced women with low fat compartments; when muscle volume decreases, a "hollowed-in" appearance in the lower face — masseter atrophy hollowing — can occur. In this case, either the dose should be reduced or micro hyaluronic acid support in the cheek and mid-face region should be planned simultaneously with masseter botox. For more detailed information, you can refer to the Layered Facial Rejuvenation Guide and Masseter Botox Glossary.
In female jawline treatment, hyaluronic acid filler is the second layer after masseter botox. Filler is used here for two purposes: chin projection (micro mentoplasty) and cheek apex support (mid-face lift). Apart from these two points — especially the gonial region — routine filler application in the female face carries the risk of masculinization, as previously stated.
Chin apex filler means applying 0.5-1.5 ml of high G-prime hyaluronic acid filler to the mentum (chin tip) region using a supraperiosteal technique over the mandibular bone. The purpose of this application is to gently project the chin apex forward, defining the lower face in a "soft egg line" shape. Liew et al.'s 2016 PDO and filler combination study published in Plastic and Reconstructive Surgery (Liew et al., 2016) showed that micro filler in the chin apex can improve light reflection along the mandibular line, perceptually slimming the lower face.
Cheek apex filler involves applying 1-2 ml of filler to the lateral-anterior mid-face compartment, below the zygomatic arch. Casabona et al.'s 2019 malar filler study published in Journal of Cosmetic Dermatology (Casabona et al., 2019) documented that supraperiosteal vector filler applied to this area reduced the appearance of jowls (cheek sagging) in the lower face by an average of 18% solely through the lift vector effect, without direct injection.
This underscores one of the most important principles of female jawline treatment: lower face contour problems are often solved not by intervening in the lower face, but in the upper face. When the upper face's "main supporting column" is strengthened by supporting mid-face volume, the lower face passively tightens. This approach yields natural and feminine results, unlike aggressive jawline filler.
In my clinical practice, the product profile I prefer for the female jawline protocol is as follows:
The total filler volume in the female jawline combination protocol usually does not exceed the 3-5 ml range. To avoid the risk of pillow face (volume overload) and an over-filled appearance, it is essential to plan the filler dose with the principle of "less is more."
Dr. Gemici's note: A common mistake I encounter in the clinic: a patient comes in saying "my jawline is undefined," has had 6-8 ml of filler done at another center, but the problem hasn't improved, and the face even looks wider. The reason is filler applied to the wrong area. The correct approach is not to increase filler volume, but to place the filler in the correct vector — upwards from the mid-face apex and forwards from the chin apex. Vector, not volume, is the key to the female jawline.
Masseter botox slims the lower face; filler defines the chin and cheek apexes. But what about the skin layer? Especially in female patients over 35, muscle and volume regulation alone are not enough — because if SMAS laxity continues along the mandibular line, the "definition" in the lower face is masked by skin sagging. This is why HIFU comes into play as the third pillar of the protocol.
HIFU focuses ultrasound energy at a depth of 4.5 mm, creating controlled thermal coagulation points (TCP) in the SMAS layer and producing a mechanical skin tightening effect. For detailed science, you can refer to the HIFU and Gold Needle Combination Guide; what is needed here from a female jawline perspective is this: applying HIFU along the mandibular line also tightens the skin envelope of the lower face, which has been slimmed by masseter botox, clarifying the contour.
In the female jawline combination, HIFU is applied with the following pass strategy:
In my clinical practice, HIFU is usually applied 4-6 weeks after the masseter botox + filler base session. There are two reasons for this interval: first, the maximum muscle slimming effect of botox comes at 8-12 weeks, and the HIFU pass is layered on top of this foundation; second, allowing 4 weeks for skin healing for filler integration is a safe protocol — direct high-energy HIFU over supraperiosteal filler is rarely preferred.
The layered protocol I apply in my clinical practice for female jawline and face contour is as follows:
The goal of this stage is to establish the basic volumetric and muscle structure. Total session duration is 45-60 minutes.
At this stage, the botox effect has reached its maximum, and filler integration is complete. The HIFU pass mechanically supports this structure. Session duration is 30-45 minutes.
This three-stage approach, unlike the pressure of "everything in one session," is a protocol that respects the natural response times of anatomy. Results vary from person to person; an individual plan is created during consultation.
The correct planning of female jawline treatment is also directly related to the patient's age and age-related tissue change pattern.
In this age group, lower face complaints are mostly based on "congenital square chin" or "masseter hypertrophy"; skin elasticity is high, SMAS laxity is minimal. The treatment plan is therefore primarily masseter botox + minimal micro chin filler. HIFU is mostly unnecessary in this age group; if added, a single session for low-intensity preventive (collagen banking) purposes may be sufficient. For details, refer to the Collagen Banking Age Plan.
In this age group, both muscle hypertrophy (if present) and early SMAS laxity have begun. Mid-face volume loss becomes prominent, and pre-jowl sulcus begins to form. The treatment plan is a full combination using all three pillars: masseter botox + chin/cheek filler + HIFU. Results are clinically most satisfying in this age range because all three layers are capable of responding to improvement.
In female patients over 45, SMAS laxity and mandibular bone resorption become prominent; masseter hypertrophy is rarely a primary problem at this age. The treatment plan in this age group is primarily HIFU + volumetric restoration; masseter botox usually takes a back seat. In some cases, the HIFU + filler combination does not yield sufficient results, and the patient may be referred for surgical lower face lift (cervicofacial lift). At this point, it is correct to transparently share the limits of the treatment and not force the patient into a non-surgical protocol.
The success of the female jawline combination protocol depends on proper patient selection.
Dr. Gemici's note: Learning to say no in a consultation is as important as learning to say yes. Fulfilling the request of a patient suspected of body dysmorphic disorder or coming with unrealistic reference photos, for the sake of "customer satisfaction," may seem like a short-term solution but turns into harm for both parties in the long run. In Dr. Hamza Gemici's clinical practice, aesthetic ethics precede commercial expectations.
The side effect profile of the combination protocol is the sum of the side effect profiles of the three treatments.
After stage 1 of the combination protocol (botox + filler), the patient can return to social activities on the same day; heavy exercise, sauna, and lying face down are avoided for the first 24 hours. Mild swelling lasts 2-5 days. After stage 2 (HIFU), erythema subsides within 24 hours; micro tenderness may last 1-3 days. Makeup can generally be applied the next day.
The three most common mistakes I see in my clinical practice for female jawline treatment are:
Applying filler to the gonial region or along the mandibular line mimics masculine anatomical features in the female face: bigonial width increases, the gonial angle sharpens. Visually, the face appears "aggressive" and "masculine." This mistake is seen in practices that either apply the patient's request without questioning or use a single-device approach without combination planning.
Cumulative loading of 4-6 ml or more filler into the cheek and mid-face region creates a "balloon" appearance on the face. This appearance, although not noticeable in filtered social media images, becomes distinctly artificial in natural light. The correct approach is the principle of "less and correct vector."
High-volume bolus + exaggerated forward projection in the chin apex region gives the face a "cylindrical chin" appearance. This appearance distorts the chin-neck angle and is aesthetically undesirable. Chin apex filler should be kept at an upper limit of 1.5 ml and individualized with clinical observation.
Asymmetric injection of masseter botox dose can create bilateral volume differences; similarly, unilateral over-dosage can create an asymmetric smile. In my clinical practice, dose titration is performed at each injection point, and symmetry is confirmed with a control session at week 2.
A rare late complication of hyaluronic acid fillers is inflammatory nodules that appear months after injection. These nodules dissolve with hyaluronidase enzyme; however, their management requires experience. Although the frequency I have observed in my clinical practice over the last 30 years is very low (<1%), patients are informed about possible complications during consultation.
Here is a set of questions I recommend to patients for a female jawline combination consultation in my clinical practice:
These questions are the most powerful tools for the patient to understand the treatment on an anatomical basis, rather than passively receiving it. A productive consultation is a harbinger of a productive treatment.
The main scientific references on which this guide is based are:
The female jawline and face contour combination protocol requires anatomy-based individual planning. You can reach us via WhatsApp for a consultation appointment at our Ataşehir clinic. Those who want a broader perspective on skin quality and aging approach can refer to our Skin Longevity program or the HIFU vs. Gold Needle comparison guide. Related glossary terms: Masseter Botox, HIFU, Filler, Mid-Face, SMAS.
For a consultation appointment
This guide is for general informational purposes only and does not constitute medical advice. Results vary depending on the individual, age, anatomy, and applied protocol; an individual treatment plan is created only after a face-to-face clinical consultation. Author: Dr. Hamza Gemici — Ondokuz Mayıs University Faculty of Medicine graduate, 30+ years of medical aesthetic experience. ORCID 0009-0007-8058-2774.
PubMed · review · Jan 1, 2014
PubMed · review · Jan 1, 2018
PubMed · guideline · Jan 1, 2016
PubMed · review · Jan 1, 2019
PubMed · review · Jan 1, 2014
PubMed · review · Jan 1, 2017
Anatomical evaluation during clinical consultation — face morphology, presence of masseter hypertrophy, and mid-face volume status — is the first step. The treatment order varies by individual; in Dr. Hamza Gemici's protocol, it usually starts with masseter botox.
The Park 2018 study reported an average reduction of 4.3 mm in bigonial width; clinical effect appears in 4-8 weeks and reaches its maximum at 8-12 weeks. Results vary depending on the individual, dose, and degree of muscle hypertrophy.
Generally, no. Gonial filler carries the risk of masculinization — a masculine angular appearance. In Dr. Hamza Gemici's clinical approach, gonial filler is rarely used in female patients, on a case-by-case basis.
In clinical practice, the chin apex bolus volume is mostly in the range of 0.5-1.5 ml. Above 1.5 ml, the risk of "sausage jaw" — cylindrical chin — increases. The individual dose is determined during consultation.
In my clinical practice, HIFU is usually added 4-6 weeks after the masseter botox + filler base session. This interval is allowed for the botox effect to plateau and for filler integration.
Mostly not necessary. Since skin elasticity is high in this age group, SMAS laxity is minimal; if HIFU is added, it is generally for low-intensity preventive purposes.
Stage 1 (botox + filler) is 1 session, Stage 2 (HIFU) is 1 session 4-6 weeks later, Stage 3 refinement is optional. The total plan is 3-6 months; results continue for 6-12 months depending on the individual.
Yes. Masseter botox can reduce bruxism symptoms — night teeth grinding, jaw clenching, morning jaw pain. Aesthetic contour and functional gain are combined in this application.
Pillow face is the "balloon face" appearance resulting from cumulative loading of 4-6 ml or more filler into the cheek and mid-face region. Avoidance: the principle of less and correct vector; total volume is usually kept below 3-5 ml.
If the old filler is hyaluronic acid, a revision can be planned; if necessary, after dissolving with hyaluronidase, the new protocol is applied. If there is permanent filler (silicone, biopolymer), the combination protocol is contraindicated.
The Casabona 2019 study showed that cheek apex filler reduced the appearance of jowls by an average of 18%. This means mid-face support passively tightens the lower face; this is a key principle of the combination.
Masseter botox effect lasts 4-6 months, hyaluronic acid filler 9-18 months, HIFU SMAS tightening 12-18 months. Results vary depending on the individual, lifestyle, and metabolic activity.
After botox and filler, on the same day; after HIFU, generally the next day. Mild swelling may last 2-5 days; makeup can be applied the next day. Recovery flow varies by individual.
If there is advanced SMAS laxity, prominent jowls, and excess skin — mostly 50+ years — the combination protocol may be insufficient, and surgical lower face lift can be considered. Dr. Hamza Gemici transparently shares the limits of the treatment.
You can reach us via WhatsApp at 0532 344 82 16 for a consultation at the Ataşehir clinic. Individual anatomical evaluation and protocol planning are created during a face-to-face consultation.

Trusted & Professional
Dr. Hamza Gemici is a medical aesthetic physician based in Ataşehir, Istanbul. His practice focuses on natural anti-aging and subtle facial harmonization using botulinum toxin, dermal fillers, periocular rejuvenation and skin quality procedures. All treatments are performed with FDA, TİTCK & CE approved products under physician-guided protocols.

May 23

May 23

May 23